News
Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
Eli Lilly and Company (NYSE:LLY) is a leading medicine company which discovers, develops, manufactures, and markets products ...
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
The worldwide dash to get goods to the U.S. ahead of President Trump's tariffs has been distorting trade patterns all year.
Zacks Investment Research on MSN14h
Septerna Stock Surges on Oral Obesity Drug Deal With Novo NordiskShares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license ...
Barchart on MSN15h
This Pharma Stock Is Still a ‘Strong Buy’ Despite Trump’s Plans to Lower Drug PricesWhile the early week buzz centered around the U.S.-China trade agreement, another critical development unfolded quietly but ...
Though Eli Lilly and Novo Nordisk have recently taken steps to make their uber-popular GLP-1 drugs more affordable for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback